Abortion, Missed
Conditions
Brief summary
the purpose of this study is to examine the success rates of Karman curettage in completing the abortion after failed recurred treatment with Misoprostol for women with missed abortion.
Interventions
DEVICEKarman curettage
Sponsors
Meir Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Healthy women diagnosed with missed abortion treated in Meir Medical Center. * The abortion occured during the first trimester of pregnancy. * Patients who chose drug therapy (Misoprostol), after retained products of conception were evident on ultrasound.
Exclusion criteria
* patients with mullarian abnormality (i.e. septal uterus, myoma etc.) * patients with significant bleeding * Endometrial wall (residua) greater than 20 mm. * known or suspected infection * known clotting defect * women after cesarean section * closed cervix
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Completing the abortion | 1 month | completing the abortion until the scheduled day for hysteroscopy, thus preventing the need for hysteroscopy |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| pregnancy | 3 months | asking the patient if she is currently pregnant |
| Pain intensity | 3 months | asking the patient about the intensity of the pain during and after the procedure, as measured with NRS-11 pain scale |
| number of days of bleeding | 3 months | asking the patient how many days of bleeding did she have after the procedure |
| number of sick days | 3 months | asking the patients how many sick leave days did she take |
| number of days of abstinence from sexual intercourse | 3 months | asking the patient how many days did she abstain from sexual intercourse after the procedure |
| infection | 3 months | asking the patient if she was diagnosed with any infection signs |
Countries
Israel
Contacts
Primary ContactMeir Pomeranz, MD
Outcome results
None listed